Searched for
NEUROCRINE BIOSCIENCES
Soleno withdraws EU rare disease drug application ahead of Neurocrine takeoverSoleno Therapeutics has withdrawn its European drug application. This decision stems from its acquirer, Neurocrine Biosciences, prioritizin...- US stocks today: US stocks end higher as investors parse US-Iran negotiations, threatsAs eyes turn towards international events, Indian investors are paying close attention. US stock markets experienced a rally, fueled by hop...
- Soleno shares jump 33% as Neurocrine expands into metabolic diseases with $2.9 billion buyoutNeurocrine Biosciences will acquire rare-disease drugmaker Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, mark...
- Stock futures market today: Bitcoin, Cryptocurrency-linked firms, Soleno Therapeutics stocks to watch out on Monday as S&P 500, Nasdaq, Dow set for mixed startStock Market futures today: Bitcoin prices jumped on Monday as U.S.-listed shares of cryptocurrency-linked firms rose, with Coinbase and St...
- Why are US stock market futures up today, and will Dow, S&P 500 and Nasdaq stay in green or turn red again? Wall Street futures rise, US stocks to watch out for, analysts insights, market outlookWhy are US stock market futures up today, and will Dow, S&P 500 and Nasdaq stay in green or turn red again? US stock futures moved higher a...
- US stock market futures climb as Dow, S&P 500, and Nasdaq rally ahead of Fed decision; Tesla, U.S. Steel surge while Sarepta crashes amid Israel-Iran tensionsUS stock market futures show Wall Street futures bouncing back, with Dow futures up 175 points after Friday’s heavy losses due to rising te...
- Lupin gets USFDA nod to market generic medicationLupin has gained approval from the USFDA to market generic Valbenazine Capsules, used to treat tardive dyskinesia. This medication is equiv...
- Lupin gets tentative USFDA approval to market generic valbenazine capsulesThese are the generic equivalent of Ingrezza capsules, 40 mg, 60 mg, and 80 mg, of Neurocrine Biosciences, Inc, it added. Valbenazine capsu...
- Lupin shares surge 5% on receiving USFDA approval for Valbenazine CapsulesLupin is a pharmaceutical company headquartered in Mumbai, India. While, it is the third-largest pharmaceutical company in the US by prescr...
Load More
